Riskpilot← Back to searchSign inGet full accessAreola AB
ABActiveOrg 5569589996Lilla Gråbrödersgatan 2 BMedical specialists activities · NACE 8622Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
-131% vs 2024
Equity ratio
98.4%
Financial strength
Net profit 2025
SEK -308
-126% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -567 | -131% |
| Net profit | SEK -308 | -126% |
| Total assets | SEK 53K | -54% |
| Equity | SEK 52K | -1% |
| Employees | 0 | — |
Legal name
Areola AB
Org number
5569589996
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 januari 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsultverksamhet inom ledning- och organisationsutveckling samt förmedla bemanningsuppdrag av medicinsk personal. Medicinsk forskning och utveckling huvudsakligen i in- och utland, och med därmed förenlig verksamhet
Address
Lilla Gråbrödersgatan 2 B
Email
olof@jarlman.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 957 | 4 688 | 3 514 | 1 189 | 0 |
| Staff expenses | — | −1 | −0 | −3 | −0 |
| EBITDA | 13 | 115 | 10 | 2 | −1 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 13 | 115 | 10 | 2 | −1 |
| Net financials | — | −0 | 1 | 0 | 0 |
| Profit before tax | 12 | 85 | 41 | 2 | −0 |
| Tax | −3 | −20 | −10 | −1 | — |
| Net profit | 9 | 65 | 30 | 1 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 075 | 1 140 | 1 479 | 115 | 53 |
| Equity | 186 | 151 | 181 | 52 | 52 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 889 | 959 | 1 298 | 62 | 1 |
| Total debt | 889 | 959 | 1 298 | 62 | 1 |
EBITDA margin
-56700.0%
This company
15.8%
Market median
-358961% vs market
20212025
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20212025
Net profit margin
-30800.0%
This company
8.1%
Market median
-380347% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2026 | |
| Deputy Board Member | 2022 – 2026 | |
| Chairman | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Areola AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Fredrik Linders | Deputy Board Member | 0 companies |
| Amelie Jarlman | Deputy Board Member | 0 companies |
| Birgitta Susanne Sihlbom | Deputy Board Member | 0 companies |
| Nils Olof Jarlman | Board of Directors | 0 companies |
| Hans Bengt Ingemar Sihlbom | Chairman | 0 companies |